Summary
What do they do? VOCAL-NY combines harm-reduction services with organizing and advocacy. The model prices direct overdose rescue against the whole charitable recipient's annual expense. Conditional central estimate: $80.4 million per10 NYC-MSA QALYs; additionality is highly uncertain.
Why we’re interested in this organization:
Direct rescue has a biologically and empirically supported route to preventing premature death.
The organization publishes reversal-event counts.
Original tax schedules separate the charity from its related Action Fund.
Our main reservations:
Fourteen reported reversals are not fourteen deaths averted.
No local controlled outcome study or current marginal staffing plan was located.
Other programs may help or harm health; their net effects remain unquantified.
What do you get for your dollar? $8.0M per DALY in New York City. DALY is our one-year comparison unit. QALY-based health gains and income-welfare equivalents retain their original assumptions; they are not measured clinical DALYs. Whole VOCAL-NY charitable recipient / conditional local direct-rescue benefit; not full-portfolio evaluation..
Reported reversal events -> recurrence-adjusted potential fatal episodes -> additional deaths prevented -> discounted quality-adjusted survival.
1. What do they do?
VOCAL-NY, EIN 13-4094385, is Voices of Community Activists & Leaders–VOCAL-NY Inc. It combines organizing with harm reduction; the related VOCAL-NY Action Fund is not the donation recipient modeled here. Original return The charity's current overdose-prevention page offers training and care coordination at 300 Douglass Street, Brooklyn. Service Its2024 report gives 14 reversal events, 645 Narcan kits and 5,438 syringe-program transactions. These are different measures and are not added together as independent lives saved. Annual report, p1
2. Monitoring and information sharing
Request incident-level rescue records, repeat-person identifiers, emergency-service response, likely severity without intervention, kit source, participant residence and subsequent mortality. Current reporting establishes activity but cannot identify counterfactual deaths. Track the effect of additional unrestricted dollars on service hours and distinct high-risk clients. Emergency rescue must be followed by effective treatment and care; this model does not claim such treatment gains.
3. Qualitative assessment
The causal pathway is staff/peer availability -> timely opioid-overdose response -> a subset of deaths prevented -> finite quality-adjusted survival. The original Massachusetts interrupted time-series study found lower overdose mortality where overdose education and naloxone were implemented, but its ecological design and older drug environment do not establish VOCAL's effect size. Study An original Medicaid cohort found high mortality after nonfatal overdose; this motivates substantial competing-mortality discounting, not a promise of 20 healthy years. Cohort No separate HIV, housing, syringe, kit-distribution or policy health benefit is added, preventing overlapping claims.
4. What do you get for your dollar?
Central cost is $9,186,268 per annual recipient-equivalent. Fourteen reported events imply $656,162 per event at whole-recipient cost, not the operating price of a rescue. The model discounts recurrence, counterfactual fatality, alternative rescue, partner credit and donation response. This gives 0.224 additional deaths prevented before geography and 0.2128 locally, or 0.0000232 local deaths prevented per $1,000. A survivor receives 0.7 quality weight, 0.08/year continuous mortality hazard (7.69% one-year mortality), 3% discounting and a 20-year horizon; the resulting local benefit is 1.14 QALYs. Thus price is $8.0M per DALY. Scenario prices span $466K to $910.0M; these are conditional stress tests, not statistical intervals. Zero additional capacity produces no finite positive price. Unmeasured external public and volunteer costs could increase social cost.
Model, assumptions and sensitivity
Whole charitable recipient expense plus reported in-kind and netted event cost; c4 affiliate excluded. Direct rescue health pathway only. Not a lower bound on whole-portfolio health.
Brooklyn direct rescue pathway inside22-county NYC MSA. g=.95 is an unverified residence assumption; other statewide/national advocacy benefits excluded. Locality of service is verified; individual residency and the location of every reported reversal are not verified.
A=sum(t=1..T)exp(-m*t)/(1+d)^t; D=N*z*l*f*r*a*b; Qall=D*u*A-h; Qlocal=g*Qall; price10=10*C/Qlocal ifQlocal>0, otherwise null.
- C
- 9186268 USD (judgment). FY2024 c3 Form990 expense 8876913 + donated services/use304045 + netted event expense5310. Excludes related Action Fund expenses. The in-kind amount is retained from consolidated reconciliation as a conservative assumption; independent c3-only allocation is not established. [990] [scheduleD]
- N
- 14 reported reversal events (observed). 2024 annual report p1 reports14 reversals; not14 deaths or14 unique people. [annual]
- z
- 0.8 fraction (judgment). Illustrative 20% survival-credit adjustment for recurrent rescues/person overlap. A repeat rescue can still prevent death; this is not a measured distinct-person fraction. Episode-specific follow-up is needed to avoid overlapping survival credit.
- l
- 1 fraction (judgment). Historical direct-rescue exposure per whole-recipient dollar retained; unrestricted allocation unknown.
- f
- 0.1 fraction (judgment). 10% of reported reversal events would otherwise be fatal, conditional on no alternative rescue. Not estimated by a VOCAL study.
- r
- 0.5 fraction (judgment). Half of potential gains remain after emergency services, other naloxone and other harm-reduction providers.
- a
- 0.8 fraction (judgment). 80% causal credit to VOCAL leaves volunteers, public supply and clinical partners credit.
- b
- 0.5 fraction (judgment). Half of unrestricted gift expands effective rescue capacity; current costed funding gap unavailable.
- g
- 0.95 fraction (judgment). 95% of direct rescue health assigned to NYC MSA; Brooklyn service location supports intersection, not measured residence.
- u
- 0.7 fraction (judgment). 0.7 quality weight among survivors; not locally measured.
- T
- 20 years (judgment). 20-year finite horizon after rescue; no added benefit after year20.
- m
- 0.08 annual mortality hazard (1/year) (judgment). Continuous all-cause mortality hazard 0.08/year implies 7.69% mortality over one year. Original post-overdose cohort supports high first-year risk; applying a constant hazard for 20 years is an unvalidated judgment. [mortality]
- d
- 0.03 fraction (judgment). 3% annual discount.
- h
- 0.00 QALYs (judgment). Unmodeled portfolio net health zero in central; adverse2-QALY scenario shows this is not a portfolio lower bound.
Conditional direct rescue: Cost: $9.2M; New York City health QALYs: 1.14; all-population health QALYs: 1.20. {"C":9186268,"N":14,"z":0.8,"l":1,"f":0.1,"r":0.5,"a":0.8,"b":0.5,"g":0.95,"u":0.7,"T":20,"m":0.08,"d":0.03,"h":0}
Lower additional rescue: Cost: $9.2M; New York City health QALYs: 0.01; all-population health QALYs: 0.01. {"C":9186268,"N":14,"z":0.5,"l":1,"f":0.03,"r":0.2,"a":0.5,"b":0.25,"g":0.8,"u":0.5,"T":10,"m":0.12,"d":0.03,"h":0}
More additional rescue: Cost: $9.2M; New York City health QALYs: 19.70; all-population health QALYs: 19.70. {"C":9186268,"N":14,"z":1,"l":1,"f":0.3,"r":0.75,"a":1,"b":0.75,"g":1,"u":0.8,"T":25,"m":0.05,"d":0.03,"h":0}
Gift does not expand rescue capacity: Cost: $9.2M; New York City health QALYs: 0.00; all-population health QALYs: 0.00. {"C":9186268,"N":14,"z":0.8,"l":1,"f":0.1,"r":0.5,"a":0.8,"b":0,"g":0.95,"u":0.7,"T":20,"m":0.08,"d":0.03,"h":0}
Half historical direct-service exposure: Cost: $9.2M; New York City health QALYs: 0.57; all-population health QALYs: 0.60. {"C":9186268,"N":14,"z":0.8,"l":0.5,"f":0.1,"r":0.5,"a":0.8,"b":0.5,"g":0.95,"u":0.7,"T":20,"m":0.08,"d":0.03,"h":0}
Unmeasured displacement outweighs modeled gain: Cost: $9.2M; New York City health QALYs: -0.76; all-population health QALYs: -0.80. {"C":9186268,"N":14,"z":0.8,"l":1,"f":0.1,"r":0.5,"a":0.8,"b":0.5,"g":0.95,"u":0.7,"T":20,"m":0.08,"d":0.03,"h":2}
Charge consolidated audit plus event cost: Cost: $9.6M; New York City health QALYs: 1.14; all-population health QALYs: 1.20. {"C":9572903,"N":14,"z":0.8,"l":1,"f":0.1,"r":0.5,"a":0.8,"b":0.5,"g":0.95,"u":0.7,"T":20,"m":0.08,"d":0.03,"h":0}
Counterfactual: Other naloxone, emergency services and harm-reduction programs continue. f is fatality without any alternative rescue; r is probability that no alternative rescue substitutes. They are distinct, uncertain judgments.
Attribution: l=1 retains historical direct-service exposure per unrestricted whole-recipient dollar. b is funding response. a assigns some causal credit to public supplies and other partners; these factors are not measured probabilities.
Very weak organization-specific causal and marginal evidence. Scenarios are conditional; no highest-EV claim or confidence interval.
Sensitivity
- Fatality counterfactual and gift-response assumptions dominate.
- Half direct-service marginal allocation doubles the price.
- A2-QALY adverse residual makes modeled net health negative; other programs are not assumed harmless.
Unresolved inputs
- Distinct-person rescue records and untreated severity.
- Matched participant residence and survival.
- Current costed funding gap and unrestricted marginal allocation.
- External public/volunteer resources and full portfolio health effects.
5. Funding and previous grants
FY2024 Form 990 expense is $8,876,913, revenue $13,060,599 and ending net assets $11,325,497. Part VIII reports $5,310 direct event expense. Schedule D reports $9,567,593 consolidated audited expense: remove $386,635 net Action Fund/consolidation adjustment and retain $304,045 donated services/use relative to the return; then add netted event expense. Central denominator is $9,186,268. The audit-plus-event sensitivity is $9,572,903. Return, Schedule D Assets are not all available cash. No costed current unrestricted funding gap was verified. The50% gift-response factor is a judgment. The official donation link redirects to a checkout; processor payee/tax standing needs final donor diligence. The $304,045 in-kind add-back comes from the consolidated reconciliation; its allocation to the c3 alone is not separately demonstrated here. Retaining it is a conservative cost assumption. Only two years of return-reported expense are available in this packet, not three separately verified annual returns.
Annual expenses
Organization-level spending, including programs, administration and fundraising. The research list averages three comparable, consecutive full fiscal years when available.
6. Sources
- 2024 Annual Report. VOCAL-NY. Published: not stated; retrieved: 2026-09-29.
- FY2024 original Form990 rendered from IRS filing202543219349328569. VOCAL-NY / IRS via ProPublica. Published: not stated; retrieved: 2026-09-29.
- FY2024 original ScheduleD audit reconciliation. VOCAL-NY / IRS via ProPublica. Published: not stated; retrieved: 2026-09-29.
- Current overdose-prevention service and Brooklyn location. VOCAL-NY. Published: not stated; retrieved: 2026-09-29.
- Original Massachusetts interrupted time-series study. Walley et al., BMJ2013. Published: not stated; retrieved: 2026-09-29.
- Original post-overdose mortality cohort. Olfson et al., JAMA Psychiatry2018. Published: not stated; retrieved: 2026-09-29.
- Official donation destination. VOCAL-NY. Published: not stated; retrieved: 2026-09-29.